 in manufacture of active ingredients, key components, inputs, et cetera, and then also in just the basic end product manufacture. Those subsidies make the Chinese companies extremely desirable trade partners, right? If a Chinese company, like one of the listed companies of concern, let's say Wuxi Biologics,